Heinke Geipel
Dr., Novartis Pharma GmbH
Heinke Geipel is listed as Dr., Novartis Pharma GmbH. Heinke spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (chair, “Erkrankungen von Rückenmark, Nerv & Muskel II”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Heinke. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
Sessions at 1 conference
DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) 4 November 2026 – 7 November 2026
- Erkrankungen von Rückenmark, Nerv & Muskel II Chair · 6 November 2026
Spoke alongside
People who have shared a session with Heinke at events on B2DB.
- Christine Klötzer Universitätsmedizin Greifswald 1 shared session
- Basil Darras Boston Children’s Hospital 1 shared session
- Crystal M. Proud 1 shared session
- Denise Dreiseidler Dr. · Novartis Pharma GmbH 1 shared session
- Nicholas E Johnson 1 shared session
- Petra Behnen Medical Lead SMA (Germany) · Novartis 1 shared session
- Uta Rager Medical Science Liaison Radioligand Therapy · Novartis 1 shared session